PROVIDER PROFILE · NPI 1891710851

Timothy MurrayMD, MBA

PRACTICEMURRAY OCULAR ONCOLOGY & RETINA INCSee all providers at this practice →

OphthalmologySouth Miami, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,625

Unique beneficiaries

—

Total services

9,751

Distinct HCPCS

Medicare payment

$733K

Peer benchmark

Total Medicare services vs. 1,263 Ophthalmology providers in FL — top quintile (cohort median 2,598).

PRESCRIBING · PART D · 2024

Total Rx claims

4,901

Beneficiaries

—

Total drug cost

$229K

Distinct drugs

Brand share

37.1%

Top prescribed drugs

Dorzolamide Hcl/Timolol Maleat1,371 claims

Gentamicin Sulfate966 claims

Dorzolamide Hcl919 claims

Latanoprost389 claims

Brimonidine Tartrate364 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$19K

Payment records

By payment type

Consulting Fee$18K

Travel and Lodging$688

Food and Beverage$451

REFERRAL NETWORK

Where Timothy Murray's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	64	134
Daniel Rivlin Dermatology · Miami Beach, FL	12	23
UNIVERSITY OF MIAMI	11	40

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history